These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 12900807

  • 1. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
    Navarro JF, Mora C, Muros M, Maca M, Garca J.
    Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
    [Abstract] [Full Text] [Related]

  • 2. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T, Altuntaş Y, Kurklu A, Aydin L, Eren N, Unsal A.
    Ren Fail; 2006 Aug; 28(2):125-8. PubMed ID: 16538969
    [Abstract] [Full Text] [Related]

  • 3. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G.
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N, Hara H, Okamura M, Egusa G, Yamakido M.
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y.
    Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):593-601. PubMed ID: 26801478
    [Abstract] [Full Text] [Related]

  • 6. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR, Lee YH, Lee SG, Kang ES, Cha BS, Lee BW.
    Cardiovasc Diabetol; 2017 Jan 26; 16(1):16. PubMed ID: 28122570
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further evidence for tubular dysfunction in insulin dependent diabetes.
    Ratzmann KP, Schimke E, Jung K, Pergande M.
    J Diabet Complications; 1989 Jan 26; 3(3):167-71. PubMed ID: 2528561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C, Velciov S, Kaycsa A, Gluhovschi G, Petrica L, Marian R, Bozdog G, Gadalean F, Bob F, Cioca D, Vernic C.
    Immunopharmacol Immunotoxicol; 2012 Feb 26; 34(1):163-9. PubMed ID: 21651460
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients.
    Weitgasser R, Schnoell F, Gappmayer B, Kartnig I.
    Diabetes Care; 1999 Nov 26; 22(11):1882-6. PubMed ID: 10546024
    [Abstract] [Full Text] [Related]

  • 13. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul 26; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 14. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A, Shima K, Fukuda M, Tahara Y, Yamamoto Y, Kumahara Y.
    Med J Osaka Univ; 1989 Mar 26; 38(1-4):57-63. PubMed ID: 2485397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-D-glucosaminidase in glomerulonephritis.
    Bazzi C, Rizza V, Olivieri G, Casellato D, D'Amico G.
    J Nephrol; 2015 Oct 26; 28(5):541-8. PubMed ID: 25227764
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.